Effects of Socioeconomic Factors and Smoking on Liver Fibrosis; A Case Study of Patients of Liver Fibrosis
DOI:
https://doi.org/10.70749/ijbr.v3i2.628Keywords:
Fibrosis, Genetic factor, Hepatitis C, MicrobiomesAbstract
A serious health risk is liver fibrosis, which can manifest in different degrees of severity in people with a persistent Hepatitis C virus (HCV) infection. This study is critical because it looks at how poverty, smoking, and environmental variables affect how people with HCV manage their liver illness. The study intends to evaluate the influence of various environmental and socioeconomic factors on the course of the disease by examining the natural history of liver fibrosis. A standardized questionnaire was created to collect information from 100 patients with Hepatitis C-related liver fibrosis. The results showed a strong correlation between the onset of liver fibrosis and extended periods of poverty. Furthermore, significant associations were found between advanced stages of liver fibrosis and environmental variables such as air pollution and occupational risks. The complicated and multifaceted character of liver fibrosis development in HCV patients is highlighted by this study, underscoring the necessity of individualized therapy regimens that include various contributing variables. The findings thoroughly comprehend how environmental factors and socioeconomic status impact the treatment of liver disease. In order to better understand the underlying processes of liver fibrosis in this group, future research paths should integrate contemporary molecular and imaging tools. These methods might eventually direct public health campaigns to enhance patient outcomes and illness management, guaranteeing improved treatment plans for individuals impacted.
Downloads
References
Barouki, R., Samson, M., Blanc, E. B., Colombo, M., Zucman-Rossi, J., Lazaridis, K. N., Miller, G. W., & Coumoul, X. (2023). The exposome and liver disease - how environmental factors affect liver health. Journal of Hepatology, 79(2), 492-505. https://doi.org/10.1016/j.jhep.2023.02.034
Beudeker, B. J., Groothuismink, Z. M., Eijk, A. A., Debes, J. D., & Boonstra, A. (2022). Circulating cytokines reflect the etiology-specific immune environment in cirrhosis and HCC. https://doi.org/10.21203/rs.3.rs-1685714/v1
Chan, H. L., Wong, G. L., Wong, V. W., Wong, M., Chan, C. Y., & Singh, S. (2021). Questionnaire survey on knowledge, attitudes, and behaviour towards viral hepatitis among the Hong Kong public. Hong Kong Medical Journal. https://doi.org/10.12809/hkmj219463
Frankova, S., Uzlova, N., Merta, D., Pitova, V., & Sperl, J. (2023). Predictors of significant liver fibrosis in people with chronic hepatitis C who inject drugs in the Czech Republic. Life, 13(4), 932. https://doi.org/10.3390/life13040932
Ho, Y. Y., Lagares, D., Tager, A. M., & Kapoor, M. (2014). Fibrosis—a lethal component of systemic sclerosis. Nature Reviews Rheumatology, 10(7), 390-402. https://doi.org/10.1038/nrrheum.2014.53
Jamalinia, M., Lonardo, A., & Weiskirchen, R. (2024). Sex and gender differences in liver fibrosis: Pathomechanisms and clinical outcomes. Fibrosis, 2(1), 10006-10006. https://doi.org/10.70322/fibrosis.2024.10006
Juanola, O., Martínez-López, S., Francés, R., & Gómez-Hurtado, I. (2021). Non-alcoholic fatty liver disease: Metabolic, genetic, epigenetic and environmental risk factors. International Journal of Environmental Research and Public Health, 18(10), 5227. https://doi.org/10.3390/ijerph18105227
Ortiz, C., Schierwagen, R., Schaefer, L., Klein, S., Trepat, X., & Trebicka, J. (2021). Extracellular matrix remodeling in chronic liver disease. Current Tissue Microenvironment Reports, 2(3), 41-52. https://doi.org/10.1007/s43152-021-00030-3
Sanyal, A. J. (2019). Past, present and future perspectives in nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology, 16(6), 377-386. https://doi.org/10.1038/s41575-019-0144-8
Sears, M. E., & Genuis, S. J. (2012). Environmental determinants of chronic disease and medical approaches: Recognition, avoidance, supportive therapy, and detoxification. Journal of Environmental and Public Health, 2012, 1-15. https://doi.org/10.1155/2012/356798
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic ovary syndrome: Etiology, current management, and future therapeutics. Journal of Clinical Medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454
Talens, M., Tumas, N., Lazarus, J. V., Benach, J., & Pericàs, J. M. (2021). What do we know about inequalities in NAFLD distribution and outcomes? A scoping review. Journal of Clinical Medicine, 10(21), 5019. https://doi.org/10.3390/jcm10215019
Xiao, J., Wang, F., Wong, N., Lv, Y., Liu, Y., Zhong, J., Chen, S., Li, W., Koike, K., Liu, X., & Wang, H. (2020). Epidemiological realities of alcoholic liver disease: Global burden, research trends, and therapeutic promise. Gene Expression, 20(2), 105-118. https://doi.org/10.3727/105221620x15952664091823
Youngstrom, E. A., Choukas-Bradley, S., Calhoun, C. D., & Jensen-Doss, A. (2015). Clinical guide to the evidence-based assessment approach to diagnosis and treatment. Cognitive and Behavioral Practice, 22(1), 20-35. https://doi.org/10.1016/j.cbpra.2013.12.005
Zein, C. O., Unalp, A., Colvin, R., Liu, Y., & McCullough, A. J. (2011). Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. Journal of Hepatology, 54(4), 753-759. https://doi.org/10.1016/j.jhep.2010.07.040
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
